Skip to main content
European Commission logo print header

Advancing Clinico-Genomic Trials on Cancer: Open Grid Services for Improving Medical Knowledge Discovery

Project description

Integrated biomedical information for better health
Harnessing grid computing to fight disease

A future in which patients receive personalised treatment based on their genetic make-up is fast becoming a reality.

But the genomic and clinical techniques that makes personalised healthcare possible has left researchers wallowing in reams of medical data. Far too often, the amount of data they have gathered surpasses their ability to analyse the information and put it to good use.

To help overcome the information overload problem, the ACGT project has successfully created a computerised system to organise such data, opening the way for the medical sector to deliver more personalised services to patients and ultimately improve health care.

By making the process of data analysis faster and more efficient, ACGT’s system permits even more rapid advances in developing treatments for a variety of diseases.

Focusing on information gathered in clinical and genomic trials involving cancer patients, the ACGT researchers developed a technical infrastructure to support the efficient sharing of such knowledge.

Drugs fine-tuned to your genes

For example, such a system would help doctors to rapidly identify what form of treatment best suits which patient, even permitting drugs to be quickly developed that are fine-tuned to their needs.

Such personalised treatment promises to give doctors a better chance of giving patients the correct medication for their condition, as well as developing treatment plans in such a way that drug side effects and other complications are minimised.

Sharing and analysing data on the grid

The backbone of the infrastructure is grid computing, which harnesses the resources of multiple, dispersed computers to gather, analyse and share data.

The project’s biomedical grid infrastructure specifically allows doctors to identify cancer profiles and best treatments rapidly, although it could be used for any disease, or for research and trials.

In addition to creating the grid infrastructure, the ACGT team also developed new methods for cross-referencing medical terms and their biological contexts. They also created common standards for storing medical research information at each level of investigation.

In doing so, they addressed issues related to data sharing, including the legal and regulatory aspects.

Tested in clinical trials

Their system allows doctors to compare accurately the results of different clinical trials and lets researchers more rapidly search for information from multiple sources.

The project partners are currently using the system in clinical trials involving patients suffering from breast cancer and paediatric nephroblastoma, a rare kind of kidney cancer that affects children and is also known as Wilms’ tumour.

Their goal is to improve further upon the results obtained so far from the combination of clinical and genetic information, which in the case of treating paediatric nephroblastoma has resulted in a success rate of up to 85%.

The completion of the Human Genome Project sparked the development of many new tools for today¿s biomedical researcher to use in finding the mechanism behind disease. While the goal is clear, the path to such discoveries has been fraught with roadblocks in terms of technical, scientific, and sociological challenges.ACGT brings together internationally recognised leaders in their respective fields, with the aim to deliver to the cancer research community an integrated Clinico-Genomic ICT environment enabled by a powerful GRID infrastructure. In achieving this objective ACGT has formulated a coherent, integrated workplan for the design, development, integration and validation of all technologically challenging areas of work. Namely: (a) GRID: delivery of a European Biomedical GRID infrastructure offering seamless mediation services for sharing data and data-processing methods and tools, and advanced security; (b) Integration: semantic, ontology based integration of clinical and genomic/proteomic data - taking into account standard clinical and genomic ontologies and metadata; (c) Knowledge Discovery: Delivery of data-mining GRID services in order to support and improve complex knowledge discovery processes.The technological platform will be validated in concrete setting of advanced clinical trials on Cancer. Pilot trials have been selected based on the presence of clear research objectives, raising the need to integrate data at all levels of the human being.ACGT promotes the principle of open source and open access, thus enabling the gradual creation of a European Biomedical Grid on Cancer. Hence, the project plans to introduce additional clinical trials during its lifecycle. It is in line with EU priorities and the objectives of the IST program. It targets the fulfilment of urgent needs of the cancer research community, a key area of societal importance and with a view to strengthening the integration of the European Research Area.

Call for proposal

See other projects for this call


EU contribution
€ 665 267,00
06410 Biot

See on map

Provence-Alpes-Côte d’Azur Provence-Alpes-Côte d’Azur Alpes-Maritimes
Activity type
Total cost
No data

Participants (24)